BioSpace News Archive

Women with platinum resistant ovarian cancer experienced longer progression free survival with relacorilant plus nab-paclitaxel than with nab-paclitaxel alone

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, reported financial results for the first quarter of 2021.

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced financial results for the first quarter ended March 31, 2021 and provided a corporate update.

Beta Bionics, Inc., a medical technology company focused on the design, development, and commercialization of the iLet® bionic pancreas system, announced the appointment of Christy Jones to its Board of Directors.

Align Technology, Inc. announced that the company is scheduled to speak at upcoming financial conferences.

Assertio Holdings, Inc., a leading commercial pharmaceutical company bringing differentiated products to patients, reported financial results for the first quarter ended March 31, 2021.

Tricida, Inc., a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis and slow CKD progression in patients with chronic kidney disease, announced financial results for the three months ended March 31, 2021 and provided an update on key initiatives.

Menin inhibitor KO-539 continues to demonstrate compelling clinical activity, favorable safety/tolerability and a wide therapeutic window

T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens, announced financial results for the three months ended March 31, 2021.

Accelerate Diagnostics, Inc. announced financial results for the first quarter for the period ended March 31, 2021.